Blog
HPLC vs LC-MS for Research Peptides: Purity, Identity and What Each Test Actually Shows
A peptide certificate of analysis can show an HPLC purity value, a mass spectrum, or both. Those data are often treated as if they prove the same thing. They do not. High-performance liquid chromatography and mass spectrometry answer different analytical questions, and understanding that distinction is one of the most useful skills in research-peptide procurement.
In simplified terms, HPLC is commonly used to separate components in a sample and estimate the relative amount represented by chromatographic peaks. Mass spectrometry evaluates ions by mass-to-charge ratio and can provide evidence that the molecular mass matches the intended compound. Combining separation and mass detection through LC-MS can therefore add identity information that a purity percentage alone cannot provide.
What HPLC tells a researcher
In reverse-phase peptide analysis, compounds are separated according to their interaction with the stationary phase and mobile phase. The detector records a chromatogram: signal intensity over retention time. A well-resolved target peak may dominate the chromatogram while smaller peaks represent impurities or related species.
The reported HPLC purity is generally based on relative peak area under the conditions used. That is useful, but it is method-dependent. Column chemistry, gradient, detector wavelength, sample preparation and integration rules all influence what is visible and how peaks are quantified.
What HPLC does not prove by itself
A large peak at a particular retention time does not independently prove that the peak is the intended peptide sequence. A different compound can sometimes elute in a similar region. Identity therefore requires orthogonal evidence.
What mass spectrometry adds
Mass spectrometry measures ions according to mass-to-charge ratio. For a peptide of known sequence, the theoretical molecular mass can be calculated in advance. Observing the expected mass pattern supports identity, while discrepancies can signal truncation, modification, adducts or another material.
LC-MS combines chromatographic separation with mass detection. This allows analysts to ask which mass signal is associated with a chromatographic peak rather than viewing the chromatogram and mass spectrum as completely separate records.
Purity and identity are different claims
| Question | Typical evidence |
|---|---|
| How much of the detected chromatographic material is in the main peak? | HPLC / UPLC peak-area data |
| Does the sample show the expected molecular mass? | MS or LC-MS |
| How much target peptide is present by mass in the vial? | Requires a quantitative content/assay approach beyond a simple purity percentage |
Why two methods are stronger than one
Analytical science often relies on orthogonal methods: techniques based on different physical principles. Chromatography may show a clean separation profile, while mass spectrometry supports molecular identity. Agreement between them is more informative than either result interpreted in isolation.
The same principle appears in the characterization of peptide reference standards, where multiple analytical methods can be integrated to establish identity, purity, content and stability. For research buyers, that is the mindset to bring to a COA: ask what each number actually measures.
Questions to ask when reading a peptide COA
- Is the HPLC chromatogram shown, or only a percentage?
- Is the mass result linked to the same lot?
- Does the measured mass align with the expected molecular species?
- Is the test date provided?
- Can the lot number on the vial be matched to the analytical report?
- Does the report distinguish purity from peptide content?
For the last point, see our companion guide: Peptide Purity vs Peptide Content.
What a strong analytical package looks like
There is no single universal test panel that answers every peptide-quality question, but a strong package uses methods that complement one another. Chromatography can profile related impurities. Mass spectrometry can support molecular identity. Quantitative assays can address content when the experiment requires it. Water, residual solvents, counterions or endotoxin may require additional methods depending on the material and intended laboratory application.
The important principle is method-to-claim alignment. If a supplier claims “identity confirmed,” look for an identity method. If it claims “99% HPLC purity,” the chromatographic evidence should support that number. If it claims a specific net amount of active peptide, chromatographic purity alone is not enough to prove the mass claim.
Red flags when reading analytical reports
- A purity percentage with no method named.
- A chromatogram that lacks sample or lot identification.
- A mass spectrum showing a value that is not explained against an expected molecular mass.
- Reports reused across multiple lots without a traceability explanation.
- “Third-party tested” language with no laboratory or report details.
None of these automatically proves a material is unsuitable, but each creates a question a laboratory buyer should resolve before treating the document as evidence.
Frequently asked research questions
Does 99% HPLC prove peptide identity?
No. It describes the chromatographic profile under a method. Identity requires evidence that the major component is the intended molecule, commonly supported by mass spectrometry or another orthogonal technique.
Is LC-MS always better than HPLC?
They answer different questions. LC-MS can combine separation with mass detection, but method suitability depends on the analytical objective. A strong package matches each method to the claim being made.
What is the first thing to check on a COA?
Confirm that the report identifies the same compound and lot as the vial, then determine which method produced each reported value.
Use documentation, not adjectives
Browse Nerolta Labs research compounds and evaluate product specifications together with the batch documentation available for your laboratory order.